Biktarvy, formally known as bictegravir, represents a powerful single-tablet therapy for managing HIV infection. This drug combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the the viral ability to copy within the body, significantly lowering the viral quantity. For many individuals